Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for ...

Zai Lab accelerates innovative drug launches in China through partnerships and expertise, targeting $1.5-$2B revenue by 2028.

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...

GENEVA -- China and the United States kicked off on Saturday a high-level meeting on economic and trade affairs in Geneva, Switzerland. As the Chinese lead person for China-US economic and trade ...

Singapore biotech firm Mirxes began trading in Hong Kong on May 23 at a valuation exceeding US$1 billion. Read more at ...

L’Oréal Groupe has backed Chinese biotech start-up Veminsyn to help identify new ingredients and speed up the process of ...

Qatar’s $526 billion sovereign wealth fund has received approval to acquire a 10 percent stake in China Asset Management Co. It is a rare Gulf investment into one of the country’s largest mutual fund ...

The investment round, valued at close to 100 million renminbi, or $13.8 million, was led by L'Oréal's China fund, its ...

With Illumina currently banned from shipping its DNA sequencers into China—in retaliation for the Trump administration’s ...

Contemporary Amperex Technology Co. Ltd., or CATL, controls more than a third of the global market for EV batteries and is ...

The largest Chinese licensing deal behind Pfizer’s is Novartis’ partnership with Shanghai Argo Biopharma, worth potentially ...